![](https://investorshub.advfn.com/uicon/158678.png?cb=1661594561)
Wednesday, July 22, 2020 2:23:57 PM
https://www.grandviewresearch.com/industry-analysis/antifungal-drugs-market"
"Say Brilacidin ends up accounting for 5% of that. $150M+ * 6% = $9M+ in freebie revenues."
The PR says....
"...in exchange for a six (6) percent fee tied to all potential future proceeds—including upfront payments, milestone payments and royalties—the Company is granting FCCDC all discovery, intellectual property and commercialization rights related to its share of their joint antifungal drug program."
....and this is the kind of misunderstanding that flows from a decision not to file or otherwise publish the details of an agreement.
You did your math using an assumption that B might do 5% of the estimated US market. The problem in doing that is that Fox isn't going to sell a B product or products....they're hoping to "downlicense" one. So it is anticipated that they will receive, as IPIX hopes to do with AS, an upfront payment, milestone payments and royalties with IPIX receiving a fee equal to 6% of those things.
By taking 6% of product revenues as the amount on which IPIX's fee is based. I believe that you are vastly overstating the potential under the agreement.
I could be mistaken of course, but I don't believe that Fox generates any product sales hence calculating IPIX's income based on estimated product sales isn't appropriate. It should be based on 6% of whatever upfront payments, milestone payments and royalties that Fox receives.
“Bad men need nothing more to compass their ends, than that good men should look on and do nothing.”
John Stuart Mill....1867
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM